Our Products
Loans
Cards
Insurance
Investment
Stock Market
Electronics Mall
CIBIL Score
Knowledge Centre
Academy 
Calculators
Our Services
My Account
Do not call
En
Biocon Ltd. Share Price
Day's Range
Day's Range
Low
₹371.05
High
₹384.50
Price Summary
| Previous Close | ₹380.60 |
|---|---|
| Day's Range | ₹371.05 - ₹384.50 |
| Open | ₹372.80 |
| 52 Week Range | ₹317.90 - ₹424.95 |
| Volume | 62,30,919 |
| Market Cap | ₹0.06 |
| Previous Close | ₹380.75 |
|---|---|
| Day's Range | ₹370.90 - ₹384.35 |
| Open | ₹373.20 |
| 52 Week Range | ₹317.90 - ₹424.95 |
| Volume | 2,84,749 |
| Market Cap | ₹0.06 |
Stocks Summary
| Trade Value ( ₹ in Lacs) | 23,714.88 |
|---|---|
| Market Cap (₹ in Mn) | 0.06 |
| Dividend Yield(%) | 0.14 |
| Price/Earning (TTM) | 98.97 |
| TTM EPS (₹) | 3.73 |
| P/E Ratio | 40.43 |
| Book Value(₹) | 1.58 |
| PAT Margin (%) | 9.32 |
| Face Value (₹) | 5.00 |
| ROCE(%) | 7.43 |
| Trade Value ( ₹ in Lacs) | 1,084.18 |
|---|---|
| Market Cap (₹ in Mn) | 0.06 |
| Dividend Yield(%) | 0.14 |
| Price/Earning (TTM) | 98.97 |
| TTM EPS (₹) | 3.73 |
| P/E Ratio | 40.43 |
| Book Value(₹) | 1.58 |
| PAT Margin (%) | 9.32 |
| Face Value (₹) | 5.00 |
| ROCE(%) | 7.43 |
Financials
| Particulars | QTR FY (₹ in Millions) | Annual FY (₹ in Millions) |
|---|---|---|
| Net sales | 5628.0 | 147557.0 |
| Expenses | N/A | N/A |
| PBT | 6039.0 | 15252.0 |
| Operating profit | 0.0 | 0.0 |
| Net profit | 5840.0 | 12978.0 |
About Biocon Ltd.
| Founded | 1978 |
|---|---|
| NSE Symbol | BIOCON |
Peer Comparision
| Stocks Name | Market Cap (Cr)(₹) | Market Price (₹) | 52 Week Low-High (₹) |
|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | 4,36,858.91 | 1,850.40 | 1,548.00 - 1,548.00 |
| Divi's Laboratories Ltd. | 1,76,617.57 | 6,676.50 | 5,636.50 - 5,636.50 |
| Torrent Pharmaceuticals Ltd. | 1,44,717.58 | 4,357.50 | 3,101.60 - 3,101.60 |
| Apollo Hospitals Enterprise Ltd. | 1,11,737.93 | 7,755.00 | 6,677.50 - 6,677.50 |
| Cipla Ltd. | 1,07,721.85 | 1,365.25 | 1,165.70 - 1,165.70 |
| Lupin Ltd. | 1,07,143.97 | 2,442.35 | 1,836.80 - 1,836.80 |
| Dr. Reddy's Laboratories Ltd. | 1,06,080.73 | 1,310.50 | 1,129.40 - 1,129.40 |
| Max Healthcare Institute Ltd. | 97,300.05 | 1,016.00 | 903.00 - 903.00 |
| Mankind Pharma Ltd. | 95,803.01 | 2,361.90 | 1,909.70 - 1,909.70 |
| Zydus Lifesciences Ltd. | 91,753.45 | 940.00 | 835.50 - 835.50 |
No Records Found
Latest News
Biocon informs about company statement
Biocon informs about press release
Biocon informs about media release
Biocon has informed that it enclosed Company Statement with respect to ‘Biocon Pharma Limited Receives U.S. FDA Approval for Dapagliflozin Tablets, 5 mg and 10 mg’. The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.
Biocon informs about analyst meet
Pursuant to Regulation 30(6) of the SEBI Listing Regulations, Biocon has informed that the Management of the Company is participating in the JP Morgan’s annual flagship India Credit Investor Trip on 11th March, 2026. The Company will not disclose any Unpublished Price Sensitive Information (UPSI) during the analyst(s)/ investor(s) meeting. The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.
Biocon informs about investor presentation
Further to its letter dated February 17, 2026 and pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Biocon has informed that it enclosed the Investor Presentation with respect to the Analyst(s)/Institutional Investor(s) meets scheduled to be held on February 25, 2026 and February 26, 2026. The above information will also be available on the website of the Company at www.biocon.com.
The above information is a part of company’s filings submitted to BSE.
No Records Found
Sign in to Unlock Offers!
We don't SPAM
Frequently Asked Questions
The current share price of Biocon Ltd. is ₹380.60 as of 2026-05-06.
The market capitalisation of Biocon Ltd. is ₹59,795.29 as of 2026-05-05.
The 1-year return of Biocon Ltd. is 0.00% as of 2026-05-06.
The P/E ratio of Biocon Ltd. is 40.43 as of 2026-05-06.
The 52-week high and low of Biocon Ltd. are ₹424.95 and ₹317.90, respectively, as of 2026-05-06.
Disclaimer
This content is for educational purpose only and the same should not be construed as investment advice. Bajaj Finserv Direct Limited shall not be liable or responsible for any investment decision that you may take based on this content.
Disclaimer
All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.
The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.
Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform.
